Real-world effect of casirivimab and imdevimab cocktail in patients infected with SARS-CoV-2 delta and omicron variants
Introduction: The casirivimab and imdevimab antibody cocktail has proven to be extremely effective against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta variant. Currently, no data on the clinical outcomes of antibody cocktail with the newer omicron form is available. This...
Saved in:
| Main Authors: | Rajas Subhash Walinjkar, Maharudra Kumbhar, Rashmi Harihar Shinde, Ekta Chaurasia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2023-03-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/17039 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of a quality by design-based ultra-performance liquid chromatography method for the simultaneous estimation of casirivimab and imdevimab with greenness metrics
by: Sravanthi Gandu, et al.
Published: (2025-06-01) -
Emergency department implementation of monoclonal antibody infusion for the treatment of coronavirus disease 2019: A template for rapid deployment
by: Thomas J. Woltemate, et al.
Published: (2021-10-01) -
Effectiveness of pharmacological treatments for COVID-19 due to SARS-CoV-2: a systematic literature review
by: Carolina Garcia Vidal, et al.
Published: (2025-02-01) -
Experimental co-infection of calves with SARS-CoV-2 Delta and Omicron variants of concern
by: Konner Cool, et al.
Published: (2024-12-01) -
Structural insight into broadening SARS-CoV-2 neutralization by an antibody cocktail harbouring both NTD and RBD potent antibodies
by: Wenling Jiang, et al.
Published: (2024-12-01)